ArticleCureus2025

Concurrent Nemolizumab-Induced Cutaneous Adverse Events and Asthma Exacerbation in a Patient With Prurigo Nodularis With Resolution of Both Conditions After Switching to Dupilumab.

Yoshihito Mima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.